Open AccessIn Vitro Activity of APX2041, a New Gwt1 Inhibitor, and In Vivo Efficacy of the Prodrug APX2104 against Aspergillus fumigatus
Author(s) -
Shareef Shaheen,
Praveen R. Juvvadi,
John Allen,
E. Keats Shwab,
Deborah Cole,
Yohannes G. Asfaw,
Mili Kapoor,
Karen Joy Shaw,
William J. Steinbach
Publication year - 2021
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00682-21
Subject(s) - aspergillus fumigatus , in vivo , aspergillosis , prodrug , azole , microbiology and biotechnology , echinocandin , in vitro , biology , pharmacology , antifungal , immunology , fluconazole , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom